Genetic predisposition to accelerated decline of lung function in COPD

por Molfino, Néstor A
Publicado 2007

A meta-analysis on the efficacy of oral theophylline in patients with stable COPD

por Molfino, Néstor A, Zhang, Peter
Publicado 2006

Gene-environment interactions in chronic obstructive pulmonary disease

por Molfino, Nestor A, Coyle, Anthony J
Publicado 2008

Challenge models to assess new therapies in chronic obstructive pulmonary disease

por van der Merwe, René, Molfino, Nestor A
Publicado 2012

Smoking and Idiopathic Pulmonary Fibrosis

por Oh, Chad K., Murray, Lynne A., Molfino, Nestor A.
Publicado 2012

A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthma

por Singh, Dave, Kane, Binita, Molfino, Nestor A, Faggioni, Raffaella, Roskos, Lorin, Woodcock, Ashley
Publicado 2010

Targeting TSLP in Asthma

por Parnes, Jane R, Molfino, Nestor A, Colice, Gene, Martin, Ubaldo, Corren, Jonathan, Menzies-Gow, Andrew
Publicado 2022

A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma

por Oh, Chad K, Leigh, Richard, McLaurin, Kimmie K, Kim, Keunpyo, Hultquist, Micki, Molfino, Nestor A
Publicado 2013

Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study

por Menzies-Gow, Andrew, Ambrose, Christopher S., Colice, Gene, Hunter, Gillian, Cook, Bill, Molfino, Nestor A., Llanos, Jean-Pierre, Israel, Elliot
Publicado 2023

Phase 2, randomised placebo-controlled trial to evaluate the efficacy and safety of an anti-GM-CSF antibody (KB003) in patients with inadequately controlled asthma

por Molfino, Nestor A, Kuna, Piotr, Leff, Jonathan A, Oh, Chad K, Singh, Dave, Chernow, Marlene, Sutton, Brian, Yarranton, Geoffrey
Publicado 2016

Effect of Biologic Therapies on Airway Hyperresponsiveness and Allergic Response: A Systematic Literature Review

por Spahn, Joseph D, Brightling, Christopher E, O’Byrne, Paul M, Simpson, Lisa J, Molfino, Nestor A, Ambrose, Christopher S, Martin, Neil, Hallstrand, Teal S
Publicado 2023

A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma

por Piper, Edward, Brightling, Christopher, Niven, Robert, Oh, Chad, Faggioni, Raffaella, Poon, Kwai, She, Dewei, Kell, Chris, May, Richard D., Geba, Gregory P., Molfino, Nestor A.
Publicado 2013

Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects...

por Parker, Joseph M, Oh, Chad K, LaForce, Craig, Miller, S David, Pearlman, David S, Le, Chenxiong, Robbie, Gabriel J, White, Wendy I, White, Barbara, Molfino, Nestor A
Publicado 2011

The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study

por Schmidt, Sigrun Alba Johannesdottir, Johansen, Martin Berg, Olsen, Morten, Xu, Xiao, Parker, Joseph M, Molfino, Nestor A, Lash, Timothy L, Sørensen, Henrik Toft, Christiansen, Christian Fynbo
Publicado 2014

Reply to Lipworth and Chan

por Ambrose, Christopher S., Israel, Elliot, Bowen, Karin, Llanos, Jean-Pierre, Martin, Neil, Cook, Bill, Hellqvist, Åsa, Korn, Stephanie, Menzies-Gow, Andrew, Roseti, Stephanie L., Molfino, Nestor A., Griffiths, Janet M., Parnes, Jane R.
Publicado 2023